Infinimmune

Infinimmune is a promising startup in the biotechnology and healthcare industries, founded in 2022. The company's mission, as reflected in its slogan "Treating human disease with truly human therapeutics," is to revolutionize the treatment of human diseases. In December 2022, Infinimmune secured a significant $12.00M Seed Round investment, drawing support from a notable group of investors including Pear Ventures, Civilization Ventures, Playground Global, Axial VC, Ron Alfa, Paul Conley, Benjamin Kim, Joshua Meier, and Jacob Becraft. This substantial investment reflects the investor confidence in Infinimmune's innovative approach and potential to make substantial contributions to the healthcare industry. With its headquarters in the United States, Infinimmune is poised to make waves in the field of human therapeutics and significantly impact the world of medicine.